Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nick Holford

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Journal of Pharmaceutical Sciences|May 8, 2013
A pharmacokinetic standard for babies and adultsNick Holford, Young-A Heo, Brian Anderson
Pharmaceutical Research|August 15, 2006
Application of clinical trial simulation to compare proof-of-concept study designs for drugs with a slow onset of effect; an example in Alzheimer's diseasePeter Lockwood, Wayne Ewy, David Hermann, et al.
Journal of Pharmacokinetics and Pharmacodynamics|March 19, 2025
Imputation of missing clock times - application to procalcitonin concentration time course after birthAbigail J Bokor, Nick Holford, Jacqueline A Hannam
Journal of Pharmacokinetics and Pharmacodynamics|October 5, 2021
Wide size dispersion and use of body composition and maturation improves the reliability of allometric exponent estimatesMario González-Sales, Nick Holford, Guillaume Bonnefois, et al.
Pharmaceutical Research|September 30, 2006
PKPD model of interleukin-21 effects on thermoregulation in monkeys--application and evaluation of stochastic differential equationsRune Viig Overgaard, Nick Holford, Klaus A Rytved, et al.
Neurorehabilitation and Neural Repair|December 5, 2009
Review: efficient rehabilitation trial designs using disease progress modeling: a pediatric traumatic brain injury exampleRob Forsyth, Thuy Vu, Cynthia Salorio, et al.
CPT: Pharmacometrics & Systems Pharmacology|January 24, 2023
Consistent methods for fat-free mass, creatinine clearance, and glomerular filtration rate to describe renal function from neonates to adultsConor J O'Hanlon, Nick Holford, Anita Sumpter, et al.
British Journal of Clinical Pharmacology|August 10, 2016
Quantitative model for the blood pressure-lowering interaction of valsartan and amlodipineYoung-A Heo, Nick Holford, Yukyung Kim, et al.
European Journal of Clinical Pharmacology|September 28, 2013
Importance of hematocrit for a tacrolimus target concentration strategyElisabet Størset, Nick Holford, Karsten Midtvedt, et al.
European Journal of Drug Metabolism and Pharmacokinetics|March 2, 2023
Population Pharmacokinetic Model for Unbound Concentrations of Daptomycin in Patients with MRSA Including Patients Undergoing HemodialysisSaki Takahashi, Yasuhiro Tsuji, Nick Holford, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Journal of Pharmaceutical Sciences|May 8, 2013
A pharmacokinetic standard for babies and adultsNick Holford, Young-A Heo, Brian Anderson
Pharmaceutical Research|August 15, 2006
Application of clinical trial simulation to compare proof-of-concept study designs for drugs with a slow onset of effect; an example in Alzheimer's diseasePeter Lockwood, Wayne Ewy, David Hermann, et al.
Journal of Pharmacokinetics and Pharmacodynamics|March 19, 2025
Imputation of missing clock times - application to procalcitonin concentration time course after birthAbigail J Bokor, Nick Holford, Jacqueline A Hannam
Journal of Pharmacokinetics and Pharmacodynamics|October 5, 2021
Wide size dispersion and use of body composition and maturation improves the reliability of allometric exponent estimatesMario González-Sales, Nick Holford, Guillaume Bonnefois, et al.
Pharmaceutical Research|September 30, 2006
PKPD model of interleukin-21 effects on thermoregulation in monkeys--application and evaluation of stochastic differential equationsRune Viig Overgaard, Nick Holford, Klaus A Rytved, et al.
Neurorehabilitation and Neural Repair|December 5, 2009
Review: efficient rehabilitation trial designs using disease progress modeling: a pediatric traumatic brain injury exampleRob Forsyth, Thuy Vu, Cynthia Salorio, et al.
CPT: Pharmacometrics & Systems Pharmacology|January 24, 2023
Consistent methods for fat-free mass, creatinine clearance, and glomerular filtration rate to describe renal function from neonates to adultsConor J O'Hanlon, Nick Holford, Anita Sumpter, et al.
British Journal of Clinical Pharmacology|August 10, 2016
Quantitative model for the blood pressure-lowering interaction of valsartan and amlodipineYoung-A Heo, Nick Holford, Yukyung Kim, et al.
European Journal of Clinical Pharmacology|September 28, 2013
Importance of hematocrit for a tacrolimus target concentration strategyElisabet Størset, Nick Holford, Karsten Midtvedt, et al.
European Journal of Drug Metabolism and Pharmacokinetics|March 2, 2023
Population Pharmacokinetic Model for Unbound Concentrations of Daptomycin in Patients with MRSA Including Patients Undergoing HemodialysisSaki Takahashi, Yasuhiro Tsuji, Nick Holford, et al.
Pageof 4